Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003590 |
---|---|
Receipt number | R000004353 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for standard therapy failed liver cancer patients. (except HCV positive patients in stage IV) |
Date of disclosure of the study information | 2010/05/10 |
Last modified on | 2017/11/13 15:49:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/10 19:53:29 | ||
2 | Update | 2010/07/16 14:39:27 | Organization1 Tel1 Email1 |
|
3 | Update | 2014/06/24 12:08:41 | Recruitment status |
|
4 | Update | 2014/07/10 16:37:15 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2017/11/13 15:49:13 | Recruitment status Anticipated trial start date |